Stifel Starts Celldex Therapeutics (CLDX) at Buy
Tweet Send to a Friend
(Updated - June 17, 2024 4:07 PM EDT)
Stifel analyst Alex Thompson initiates coverage on Celldex Therapeutics (NASDAQ: CLDX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Alex Thompson initiates coverage on Celldex Therapeutics (NASDAQ: CLDX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


